Could the reason why the placebo effect works for some people and not others lie in their DNA? The authors of a new scientific review article make the case that,…
Read More
After June 21, Medicare will limit coverage for the core drug-sensitivity genetic tests that comprise YouScript’s Polypharmacy test panel. This means that if you or a loved one are 65…
Read More
Recent research sponsored by Genelex and undertaken by University of Utah researchers has been recognized at the national Academy of Managed Care Pharmacy (AMCP) conference. The research shows that as many…
Read More
By Howard Coleman, Genelex CEO The week of May 9 saw scores of scientists, researchers and clinical laboratory professionals descend on the nation’s capital for the annual American Clinical Laboratory…
Read More
Researchers seeking to fill a knowledge gap in what’s known about the magnitude of pediatric drug-related ER visits have found that 1 in 12 ER trips for children involved medications.…
Read More
Physicians and family taking care of a 6-year-old boy diagnosed with attention deficit hyperactivity disorder (ADHD) found a common medication used to treat the condition was having the reverse effect.…
Read More
Why do some patients react differently to the same drug? A study using data analyzed by the YouScript Personalized Prescribing Software has quantified the role genotypes may play in causing adverse…
Read More
New research offers more evidence for the connection between CYP2C9 and VKORC1 variants and increased bleeding risk in patients taking warfarin. A large-scale study published in the March edition of…
Read More
One day after a 5½-year-old boy was released from the hospital for a routine tonsillectomy, he was comatose in the ER. The boy had undergone surgery to remove his tonsils…
Read More
A cyberattack may have compromised the personal information of approximately 11 million customers insured by Premera Blue Cross. On January 29, 2015, Premera discovered that attackers may have gained access…
Read More
